Galapagos NV(GLPG),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GLPG Galapagos NV

Market Closed 05-07 16:00:00 EDT

27.73

+0.00

0.00%

High27.73	Low27.73	Vol0.00
Open27.73	D1 Closing27.73	Amplitude0.00%
Mkt Cap1.83B	Tradable Cap1.80B	Total Shares65.90M
T/O8.03M	T/O Rate0.00%	Tradable Shares65.05M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"GLPG","market":"US","secType":"STK","nameCN":"Galapagos NV","latestPrice":27.73,"timestamp":1778184000000,"preClose":27.73,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":65046221,"shares":65897071,"eps":0,"marketStatus":"Market Closed","change":0,"latestTime":"05-07 16:00:00 EDT","open":27.73,"high":27.73,"low":27.73,"amount":8026086.3166,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"symbolChange":{"newSymbol":"LKFT","executeDate":"2026-05-08"},"adr":1,"adrRate":1,"listingDate":1431576000000,"exchange":"NASDAQ","adjPreClose":27.73,"volumeRatio":0},"requestUrl":"/m/hq/s/GLPG","defaultTab":"news","newsList":[{"id":"2633118595","title":"Galapagos NV reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2633118595","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633118595?lang=en_us&edition=fundamental","pubTime":"2026-05-07 15:29","pubTimestamp":1778138969,"startTime":"0","endTime":"0","summary":"Galapagos NV reports results for the quarter ended March 31 - Earnings SummaryGalapagos NV GLPG.OQ reported quarterly adjusted earnings of 11.87 per share for the quarter ended March 31, lower than th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nL8N41K0M6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LKFT","BK4139","GLPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633159917","title":"Galapagos Q1 EPS US$0.25 Beats US$(1.27) Estimate, Sales US$7.589M Miss US$16.040M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2633159917","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633159917?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:03","pubTimestamp":1778097836,"startTime":"0","endTime":"0","summary":"Galapagos (NASDAQ:GLPG) reported quarterly earnings of $0.25 per share which beat the analyst consensus estimate of $(1.27) by 119.69 percent. This is a 110.12 percent increase over losses of $(2.47) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52342402/galapagos-q1-eps-us-0-25-beats-us-1-27-estimate-sales-us-7-589m-miss-us-16-040m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Galapagos Q1 EPS US$0.25 Beats US$(1.27) Estimate, Sales US$7.589M Miss US$16.040M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLPG","BK4139","LKFT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633737962","title":"Galapagos NV  expected to post a loss of €1.31 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2633737962","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633737962?lang=en_us&edition=fundamental","pubTime":"2026-05-05 07:12","pubTimestamp":1777936333,"startTime":"0","endTime":"0","summary":"Galapagos NV  expected to post a loss of 1.31 a share - Earnings Preview Galapagos NV GLPG.OQ, GLPG.O is expected to  show a fall in quarterly revenue when it reports  results on May 6 for the period ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nL8N41H2OW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLPG","BK4139","LKFT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195858304","title":"Earning Preview: Galapagos NV Q1 revenue is expected to decrease by 81.55%, institutional views are cautious","url":"https://stock-news.laohu8.com/highlight/detail?id=1195858304","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195858304?lang=en_us&edition=fundamental","pubTime":"2026-04-30 03:06","pubTimestamp":1777489582,"startTime":"0","endTime":"0","summary":"Abstract Galapagos NV will report results on May 06, 2026 Post Market; this preview outlines consensus expectations on revenue, margins and adjusted EPS alongside recent performance trends and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Earning Preview: Galapagos NV Q1 revenue is expected to decrease by 81.55%, institutional views are cautious","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625953345","title":"RBC Adjusts Price Target on Galapagos NV to $28 From $33, Maintains Sector Perform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2625953345","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625953345?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:48","pubTimestamp":1775566108,"startTime":"0","endTime":"0","summary":"Galapagos NV (GLPG) has an average rating of hold and mean price target of $32.69, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GLPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623307668","title":"Galapagos, Gilead enter pact to collaborate on T cell engager therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2623307668","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623307668?lang=en_us&edition=fundamental","pubTime":"2026-03-31 17:30","pubTimestamp":1774949454,"startTime":"0","endTime":"0","summary":"Galapagos (GLPG) announced that it has entered into a binding agreement with Gilead (GILD) in connection with Gilead’s definitive agreement to acqu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/galapagos-gilead-enter-pact-to-collaborate-on-t-cell-engager-therapies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/galapagos-gilead-enter-pact-to-collaborate-on-t-cell-engager-therapies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1934455194.USD","SG9999015986.USD","LU0320765992.SGD","LU1674673428.USD","LU1934455277.USD","IE0002270589.USD","LU2324357040.USD","LU1057294990.SGD","BK4139","LU0965509101.SGD","BK4583","GILD","LU0889565916.HKD","LU0861579265.USD","LU0965509010.AUD","LU2089984988.USD","BK4585","LU2468319806.SGD","LU0109394709.USD","SG9999015945.SGD","LU2087621335.USD","LU1037948897.HKD","IE00BSNM7G36.USD","LU1430594728.SGD","LU1571399168.USD","GLPG","LU1023059063.AUD","IE00B7SZLL34.SGD","BK4578","LU1037948541.HKD","LU0823416689.USD","SG9999015952.SGD","IE00BKVL7J92.USD","SG9999015978.USD","BK4550","LU0965509283.SGD","LU0114720955.EUR","BK4532","LU0882574055.USD","LU0058720904.USD","LU1066053197.SGD","LU0122379950.USD","BK4568","IE00B3T34201.USD","LU1934455863.HKD","LU0234570918.USD","IE00B19Z3B42.SGD","LU1066051498.USD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623370691","title":"Press Release: Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2623370691","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623370691?lang=en_us&edition=fundamental","pubTime":"2026-03-31 13:30","pubTimestamp":1774935000,"startTime":"0","endTime":"0","summary":"New collaboration structure achieves meaningfully improved financial terms and flexibility for Galapagos. Following this transaction, the Company will continue to have a majority of its cash remaining for additional strategic transactions and other capital allocation priorities. Opportunity to develop a potential first-in-class & best-in-class T cell engager in autoimmune diseases with gamgertamig. Management to host conference call today, March 31, 2026, at 14:00 CET / 8:00 am ET. Gamgertamig  is a clinical--stage BCMAxCD3 T cell engager designed to enable rapid and deep plasma and B--cell depletion following a short duration, subcutaneously administered treatment course. In ongoing Phase 1/2 clinical studies, gamgertamig has demonstrated transformative efficacy and a differentiated safety profile after a single treatment cycle in severe antibody-mediated orphan diseases, including autoimmune hemolytic anemia  and immune thrombocytopenia . Gamgertamig has been granted both Fast Track ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ITP","GLPG","BK4139","BK4199"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622992338","title":"Galapagos chairman Jerome Contamine to step down, Gino Santini to succeed","url":"https://stock-news.laohu8.com/highlight/detail?id=2622992338","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622992338?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:41","pubTimestamp":1774557660,"startTime":"0","endTime":"0","summary":"Galapagos (GLPG) announced the proposed appointment of Gino Santini as a non-executive independent director, with the intention to appoint him as c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/galapagos-chairman-jerome-contamine-to-step-down-gino-santini-to-succeed-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/galapagos-chairman-jerome-contamine-to-step-down-gino-santini-to-succeed-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GLPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622089675","title":"Galapagos Nominates Santini Board, Succeeding Contamine","url":"https://stock-news.laohu8.com/highlight/detail?id=2622089675","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622089675?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:15","pubTimestamp":1774556100,"startTime":"0","endTime":"0","summary":"Galapagos nominated Gino Santini to its board of directors with the intention of appointing him chair.If elected to the board, Santini would succeed current chair Jérme Contamine, whose term on the board will end following the biotechnology company's annual shareholders meeting on April 28.Since leaving Lilly, Santini has served as an adviser or board member to several pharmaceutical and biotechnology companies, Galapagos said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622018994","title":"Sector Update: Health Care Stocks Advance Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2622018994","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622018994?lang=en_us&edition=fundamental","pubTime":"2026-03-25 03:50","pubTimestamp":1774381826,"startTime":"0","endTime":"0","summary":"Health care stocks rose late Tuesday afternoon, with the NYSE Health Care Index adding 0.4% and the State Street Health Care Select Sector SPDR ETF  up 0.2%.The iShares Biotechnology ETF  shed 0.4%.In corporate news, CVS Health  has reached a proposed settlement with the Federal Trade Commission over insulin pricing, Reuters reported, citing the company. The company's pharmacy benefit management unit, Caremark, has focused on lowering prescription drug costs, CVS said, adding that the settlement is expected to be finalized in the coming weeks, with final terms still pending, the report said. CVS shares rose 2.5%.ImmunityBio  shares dropped 21% after the US Food and Drug Administration issued a warning letter citing \"misleading\" promotional materials for its bladder cancer drug Anktiva.Gilead Sciences  has agreed to acquire autoimmune disease therapy developer Ouro Medicines for up to $2.18 billion, while the biopharmaceutical firm is in collaboration talks with Galapagos  on the assets","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0965508806.USD","GLPG","IE00B7SZLL34.SGD","LU1674673691.USD","IE0002270589.USD","LU0889565916.HKD","LU2089984988.USD","BK4550","LU0211331839.USD","IBB","GILD","LU1934455277.USD","KPTI","LU0289739699.SGD","XBI","LU0061475181.USD","BK4588","BK4139","LU1778281490.HKD","LU1934455194.USD","LU1066051498.USD","BK4504","LU1061106388.HKD","IE00BSNM7G36.USD","LU2112291526.USD","LU0861579265.USD","LU0965509283.SGD","LU1066053197.SGD","CVS","IE00B19Z3B42.SGD","LU0823416689.USD","LABU","LU0070302665.USD","SG9999015986.USD","LU0058720904.USD","LU2087621335.USD","LU0234570918.USD","LU0072461881.USD","LU1059921491.USD","LU1699723380.USD","LU0006061336.USD","CVS.AU","LU0114720955.EUR","IBRX","LU0965509010.AUD","BK4196","XLV","LU0208291251.USD","LU0109394709.USD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621060978","title":"Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2621060978","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621060978?lang=en_us&edition=fundamental","pubTime":"2026-03-24 21:19","pubTimestamp":1774358371,"startTime":"0","endTime":"0","summary":"Health care stocks were mixed pre-bell Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.2% and the iShares Biotechnology ETF (IBB) slightly higher.Galapagos (GLPG) said i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4583","XBI","SG9999015945.SGD","LU0823416689.USD","LU0861579265.USD","LU0109394709.USD","KPTI","LU0320765992.SGD","LU1430594728.SGD","GLPG","LU1778281490.HKD","GILD","LU2087621335.USD","LU2468319806.SGD","IE00BKVL7J92.USD","IBB","OCGN","BK4581","IE0002270589.USD","IE00B3T34201.USD","LU2324357040.USD","SG9999015952.SGD","LU0965509101.SGD","LU0289739699.SGD","BK4532","LU1037948897.HKD","LABU","LU1061106388.HKD","IE00BSNM7G36.USD","SG9999015978.USD","LU0114720955.EUR","IE00B7SZLL34.SGD","LU1934455277.USD","IE00B19Z3B42.SGD","LU1674673691.USD","BK4563","LU1023059063.AUD","BK4566","LU0965509283.SGD","LU0889565916.HKD","LU1066053197.SGD","LU1057294990.SGD","LU0234570918.USD","XLV","LU0882574055.USD","LU0058720904.USD","BK4578","BK4139","LU1571399168.USD","LU0965508806.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619463303","title":"Morgan Stanley Keeps Their Sell Rating on Galapagos (GLPG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2619463303","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619463303?lang=en_us&edition=fundamental","pubTime":"2026-03-16 20:38","pubTimestamp":1773664692,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst Judah Frommer maintained a Sell rating on Galapagos today and set a price target of $22.00. Frommer covers the Healthcare se...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-keeps-their-sell-rating-on-galapagos-glpg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-keeps-their-sell-rating-on-galapagos-glpg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618993195","title":"Galapagos (GLPG) Gets a Sell from Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2618993195","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618993195?lang=en_us&edition=fundamental","pubTime":"2026-03-10 18:35","pubTimestamp":1773138945,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst Judah Frommer maintained a Sell rating on Galapagos yesterday and set a price target of $22.00. The company’s shares closed ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/galapagos-glpg-gets-a-sell-from-morgan-stanley-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/galapagos-glpg-gets-a-sell-from-morgan-stanley-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0106261372.USD","BK4516","LU1989772923.USD","IE00BKVL7J92.USD","LU0320765646.SGD","LU0912757837.SGD","LU0971096721.USD","LU2133065610.SGD","LU1791710400.SGD","LU1720051017.SGD","LU1791710582.SGD","LU2111349929.HKD","LU1162221912.USD","LU2271345857.HKD","LU2347655156.SGD","LU0314104364.USD","LU1363072403.SGD","LU1244550494.USD","LU1244550577.SGD","LU0006306889.USD","LU1732799900.SGD","BK4534","LU2089283258.USD","BK4581","LU2089284900.SGD","LU0267386448.USD","BK4127","LU1668664300.SGD","LU2023251221.USD","LU2357305700.SGD","LU2028103732.USD","LU0557290698.USD","LU1244550221.USD","LU0795875169.SGD","GLPG","LU0158827948.USD","LU0225283273.USD","LU1548497426.USD","BK4585","LU1732800096.USD","LU0882574139.USD","LU0234570918.USD","BK4588","LU1989772840.SGD","LU0158827781.USD","LU1720051108.HKD","BK4139","IE00BZ1G4Q59.USD","LU1074936037.SGD","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617792455","title":"Galapagos CHRO Annelies Missotten to step down, Tania Philipp to succeed","url":"https://stock-news.laohu8.com/highlight/detail?id=2617792455","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617792455?lang=en_us&edition=fundamental","pubTime":"2026-03-06 05:40","pubTimestamp":1772746839,"startTime":"0","endTime":"0","summary":"Galapagos (GLPG) announced the appointment of Tania Philipp as chief human resources officer, or CHRO, effective March 4. Philipp will also join th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/galapagos-chro-annelies-missotten-to-step-down-tania-philipp-to-succeed-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/galapagos-chro-annelies-missotten-to-step-down-tania-philipp-to-succeed-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614203907","title":"Galapagos Is Maintained at Sector Perform by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2614203907","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614203907?lang=en_us&edition=fundamental","pubTime":"2026-02-25 23:59","pubTimestamp":1772035140,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GLPG/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 25, 2026 10:59 ET (15:59 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0708994859.HKD","BK4207","LU0128525929.USD","LU0310800379.SGD","LU0029864427.USD","BK4139","GLPG","LU1267930573.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614033953","title":"RBC Capital Adjusts Galapagos NV PT to $33 From $32, Maintains Sector Perform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2614033953","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614033953?lang=en_us&edition=fundamental","pubTime":"2026-02-25 22:21","pubTimestamp":1772029262,"startTime":"0","endTime":"0","summary":"RBC Capital Adjusts Galapagos NV PT to $33 From $32, Maintains Sector Perform Rating","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GLPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614572285","title":"Galapagos NV Earnings Call: Cash Rich, In Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2614572285","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614572285?lang=en_us&edition=fundamental","pubTime":"2026-02-25 08:10","pubTimestamp":1771978236,"startTime":"0","endTime":"0","summary":"Galapagos NV (($GLPG)) has held its Q4 earnings call. Read on for the main highlights of the call. Galapagos NV’s latest earnings call painted a ca...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/galapagos-nv-earnings-call-cash-rich-in-transition?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/galapagos-nv-earnings-call-cash-rich-in-transition?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613753330","title":"Galapagos 2025 Earnings, Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2613753330","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613753330?lang=en_us&edition=fundamental","pubTime":"2026-02-24 06:20","pubTimestamp":1771885202,"startTime":"0","endTime":"0","summary":"Galapagos (GLPG) reported 2025 earnings late Monday of 4.87 euros ($5.74) per diluted share, up from 1.12 euros a year earlier.Net revenue for the year ended Dec. 31 rose to 1.11 billion euros from 275.6 million euros a year earlier.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GLPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613758687","title":"Galapagos Q4 EPS $13.82 increased from $0.30, Sales $1.049B increased from $80.575M","url":"https://stock-news.laohu8.com/highlight/detail?id=2613758687","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613758687?lang=en_us&edition=fundamental","pubTime":"2026-02-24 05:50","pubTimestamp":1771883455,"startTime":"0","endTime":"0","summary":"Galapagos (NASDAQ:GLPG) reported quarterly earnings of $13.82 per share. This is a 4506 percent increase over earnings of $0.30 per share from the same period last year. The company reported quarterly sales of $1.049","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/02/50801547/galapagos-q4-eps-13-82-increased-from-0-30-sales-1-049b-increased-from-80-575m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Galapagos Q4 EPS $13.82 increased from $0.30, Sales $1.049B increased from $80.575M","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.glpg.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":-0.1255},{"period":"1year","weight":-0.1481},{"period":"ytd","weight":-0.152}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0106},{"period":"3month","weight":0.0304},{"period":"6month","weight":0.154},{"period":"1year","weight":0.1622},{"period":"ytd","weight":0.1208}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.029049},{"month":2,"riseRate":0.181818,"avgChangeRate":-0.055722},{"month":3,"riseRate":0.363636,"avgChangeRate":0.000347},{"month":4,"riseRate":0.545455,"avgChangeRate":-0.006786},{"month":5,"riseRate":0.363636,"avgChangeRate":0.027968},{"month":6,"riseRate":0.181818,"avgChangeRate":-0.039259},{"month":7,"riseRate":0.636364,"avgChangeRate":0.068834},{"month":8,"riseRate":0.181818,"avgChangeRate":-0.030314},{"month":9,"riseRate":0.454545,"avgChangeRate":-0.018717},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.009712},{"month":11,"riseRate":0.454545,"avgChangeRate":-0.004236},{"month":12,"riseRate":0.727273,"avgChangeRate":0.051262}],"exchange":"NASDAQ","name":"Galapagos NV","nameEN":"Galapagos NV","securityTypeName":"DR","adrRate":"1:1"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Galapagos NV(GLPG),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Galapagos NV(GLPG) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Galapagos NV,GLPG,Galapagos NV股票,Galapagos NV股票老虎,Galapagos NV股票老虎国际,Galapagos NV行情,Galapagos NV股票行情,Galapagos NV股价,Galapagos NV股市,Galapagos NV股票价格,Galapagos NV股票交易,Galapagos NV股票购买,Galapagos NV股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Galapagos NV(GLPG),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Galapagos NV(GLPG) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction